Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.550
-0.030-1.16%
Volume:100.00K
Turnover:259.44K
Market Cap:1.40B
PE:-6.67
High:2.630
Open:2.580
Low:2.550
Close:2.580
52wk High:4.280
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:0.58
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.382
ROE:-13.89%
ROA:-8.82%
PB:0.86
PE(LYR):-6.67
PS:34.28

Loading ...

Lee's Pharmaceutical Enters Exclusive Licensing and Supply Deal for Interferon Alpha-2b Outside Greater China

Stock News
·
Jul 17

Key Corporate Updates from Hong Kong-Listed Companies: Strategic Alliances, Financial Results, and Regulatory Milestones

Stock News
·
Jul 14

Zhaoke Ophthalmology acquires global rights to pediatric-myopia drug NVK002

Bulletin Express
·
Jul 13

Zhaoke Ophthalmology-B Secures Worldwide Rights for NVK002 Atropine Sulfate Eye Drops

Stock News
·
Jul 13

Zhaoke Ophthalmology Ltd - Entered into Definitive Agreement for Acquisition of Global Rights to Nvk002

THOMSON REUTERS
·
Jul 13

Zhaoke Ophthalmology - Grants Perpetual Royalty-free Exclusive U.S. Nvk002 License to Nevakar Pharmaceuticals

THOMSON REUTERS
·
Jul 13

Zhaoke Ophthalmology: Cumulative Share Buybacks Reach 1.72 Million Shares, Representing 0.31% of Issued Capital

Bulletin Express
·
Jul 09

Zhaoke Ophthalmology-B (06622) Repurchases 8,500 Shares for HK$22,100 on July 9

Stock News
·
Jul 09

Zhaoke Ophthalmology-B's Innovative Presbyopia Treatment YUVEZZI™ Approved for Import and Use at Boao Super Hospital

Stock News
·
Jul 07

Zhaoke Ophthalmology Gains Hainan Approval for YUVEZZI™, China’s First Innovative Presbyopia Therapy

Bulletin Express
·
Jul 07

Zhaoke Ophthalmology - Yuvezzitm Approved for Use at Boao Super Hospital as Clinically Urgent Imported Drug

THOMSON REUTERS
·
Jul 07

Zhaoke Ophthalmology Ltd - Approval from Hainan Provincial Medical Products Administration

THOMSON REUTERS
·
Jul 07

Zhaoke Ophthalmology Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jul 07

Zhaoke Ophthalmology Buys Back 7,500 Shares on 3 July; Cumulative 1.70 Million Shares Repurchased Since Mandate

Bulletin Express
·
Jul 03

Zhaoke Ophthalmology repurchases 39,500 shares; total buybacks reach 1.69 million, 3.08% of 2026 mandate utilised

Bulletin Express
·
Jul 03

Zhaoke Ophthalmology Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jul 03

Zhaoke Ophthalmology buys back 1.65 million shares in June, equal to 0.30% of share capital

Bulletin Express
·
Jun 30

Zhaoke Ophthalmology-B Allocates Approximately HK$229,400 for Share Repurchase on June 30

Stock News
·
Jun 30

Kangda International Environmental Names Liew Fui Kiang Independent Non-executive Director

Reuters
·
Jun 29

Zhaoke Ophthalmology repurchases 1.56 million shares; issued share capital unchanged at 548.75 million

Bulletin Express
·
Jun 29